Ana Isabel Rebollo-Giménez,Talia Baird,Brian M Feldman,Claas Hinze,Liza J McCann,Ann M Reed,Lisa G Rider,Jessie Cunningham,Alessandro Consolaro,Angelo Ravelli,Jayne Monica MacMahon,Silvia Rosina
{"title":"Systematic literature review informing PReS/CARRA-endorsed recommendations for the treat-to-target strategy in juvenile dermatomyositis.","authors":"Ana Isabel Rebollo-Giménez,Talia Baird,Brian M Feldman,Claas Hinze,Liza J McCann,Ann M Reed,Lisa G Rider,Jessie Cunningham,Alessandro Consolaro,Angelo Ravelli,Jayne Monica MacMahon,Silvia Rosina","doi":"10.3899/jrheum.2025-1157","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nTo seek for the current evidence in support of the adoption of the treat-to-target (T2T) strategy in the management of juvenile dermatomyositis (JDM).\r\n\r\nMETHODS\r\nA systematic literature review (SLR) was performed to address 14 research questions formulated by the Steering Committee (SC) of the project. MEDLINE, Embase, Cochrane Central, and Web of Science databases were searched for clinical trials, observational studies (retrospective and prospective), case reports of > 2 patients, expert recommendations, and systematic reviews published until March 2023. The protocol for the SLR was registered in PROSPERO (CRD42023421254). Quality assessment was performed according to a modified GRADE approach.\r\n\r\nRESULTS\r\nA total of 2,714 articles were retrieved from the databases, with an additional 47 identified through citation searching, and 23 flagged by SC members. Of these, 220 were included in the final review. Evidence was strong or moderate for 2 and 22 articles, respectively, and weak for the remaining articles. Although no published study that compared conventional management with a targeted approach was retrieved, useful insights into specific therapeutic endpoints and optimal timing for their achievement that could be considered in designing the T2T strategy for JDM were obtained.\r\n\r\nCONCLUSION\r\nThis SLR provides a comprehensive overview of the current knowledge that served as the basis for the consensus definition of the overarching principles and recommendations for treating JDM to target.","PeriodicalId":501812,"journal":{"name":"The Journal of Rheumatology","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3899/jrheum.2025-1157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
To seek for the current evidence in support of the adoption of the treat-to-target (T2T) strategy in the management of juvenile dermatomyositis (JDM).
METHODS
A systematic literature review (SLR) was performed to address 14 research questions formulated by the Steering Committee (SC) of the project. MEDLINE, Embase, Cochrane Central, and Web of Science databases were searched for clinical trials, observational studies (retrospective and prospective), case reports of > 2 patients, expert recommendations, and systematic reviews published until March 2023. The protocol for the SLR was registered in PROSPERO (CRD42023421254). Quality assessment was performed according to a modified GRADE approach.
RESULTS
A total of 2,714 articles were retrieved from the databases, with an additional 47 identified through citation searching, and 23 flagged by SC members. Of these, 220 were included in the final review. Evidence was strong or moderate for 2 and 22 articles, respectively, and weak for the remaining articles. Although no published study that compared conventional management with a targeted approach was retrieved, useful insights into specific therapeutic endpoints and optimal timing for their achievement that could be considered in designing the T2T strategy for JDM were obtained.
CONCLUSION
This SLR provides a comprehensive overview of the current knowledge that served as the basis for the consensus definition of the overarching principles and recommendations for treating JDM to target.
目的寻找支持治疗到目标(T2T)策略在青少年皮肌炎(JDM)治疗中的现有证据。方法采用系统文献综述(SLR),对项目指导委员会(SC)制定的14个研究问题进行分析。我们检索了MEDLINE、Embase、Cochrane Central和Web of Science数据库,检索了截至2023年3月发表的临床试验、观察性研究(回顾性和前瞻性)、bb20例患者的病例报告、专家建议和系统评价。SLR协议在PROSPERO (CRD42023421254)中注册。根据改进的GRADE方法进行质量评估。结果从数据库中检索到2714篇文章,另有47篇通过引文检索确定,23篇由SC成员标记。其中220项列入最后审查。2篇和22篇文章分别为强证据或中等证据,其余文章为弱证据。虽然没有发表的研究将传统治疗与靶向治疗进行比较,但我们获得了关于特定治疗终点和最佳实现时间的有用见解,可以在设计JDM的T2T治疗策略时加以考虑。结论:本SLR提供了当前知识的全面概述,作为JDM治疗目标的总体原则和建议的共识定义的基础。